Target intelligence / Profile preview

Endometrial regeneration

Molecular classification
Biological process
01

Overview

Endometrial regeneration is the cyclic physiological process by which the functional layer of the uterine lining is restored following menstruation, parturition, or surgical injury (Gargett et al., 2016). This process is characterized by rapid tissue remodeling, involving the proliferation of epithelial and stromal cells, extensive angiogenesis, and the activation of resident endometrial stem/progenitor cells located in the basal layer (Critchley et al., 2020). The primary physiological driver of this regeneration is estrogen, which acts through its receptors to trigger mitogenic pathways and prepare the uterus for embryo implantation (Santamaria et al., 2018). Pathological failure of this process results in conditions such as Asherman's syndrome or a persistently thin endometrium, both of which are major contributors to uterine factor infertility (Dreisler & Kjer, 2019). While 'endometrial regeneration' itself is a biological process rather than a single molecular target, it is the focus of various therapeutic interventions including high-dose estrogen therapy, growth factor administration (e.g., G-CSF), and regenerative medicine techniques like stem cell transplantation (Zheng et al., 2020). Understanding the molecular pathways governing this regeneration, such as the Wnt/beta-catenin and TGF-beta signaling pathways, is crucial for developing targeted treatments for menstrual disorders and infertility (Tan et al., 2022).

Other names
Endometrial repairUterine lining restorationEndometrial remodelingEndometrial proliferation
02

Mechanism of action

Modulation of the endometrial microenvironment through hormonal stimulation of the Estrogen Receptor, recruitment of bone marrow-derived stem cells, and induction of angiogenic factors to promote tissue regrowth.

03

Biological functions

Tissue repairCell proliferationAngiogenesisStem cell activationHormonal response
04

Disease associations

Asherman's syndromeInfertilityEndometrial hypoplasiaThin endometriumMenstrual disorders
05

Safety considerations

Risk of endometrial hyperplasiaPotential for endometrial carcinoma with unopposed estrogenIntrauterine adhesion recurrenceSystemic side effects of high-dose steroids
06

Interacting drugs

Estradiol

4 more in the full profile.

07

Biomarkers

Endometrial thickness (EMT)Ki-67 proliferation indexVascular endothelial growth factor (VEGF)CD133+ stem cell markersLeukemia inhibitory factor (LIF)

Beyond the preview

Go deeper on Endometrial regeneration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endometrial regeneration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call